Dr Yeo Pei Ming

Dr Yeo received her undergraduate medical education at the National University of Singapore. She commenced her internal medicine training in Tan Tock Seng Hospital and obtained the Membership of the Royal College of Physicians of the United Kingdom (MRCP, UK). She subsequently pursued her specialist training in Dermatology in Singapore. 

She sees all patients with general dermatological problems. Her special interests are in skin cancers and Mohs Micrographic Surgery. She has published multiple articles in peer-reviewed journals and currently serves as a clinical tutor for LKCMedicine and Duke-NUS.

• MBBS (Singapore)
• MRCP (United Kingdom)

• NTU Lee Kong Chian School of Medicine Faculty Appointment – Clinical Instructor
• Duke-NUS Faculty Appointment - Clinical Instructor
• Tutor in SKH Dermatology-GP Clinical Observership
• Deputy coordinator for the MRCP PACES Exams held in Sengkang General Hospital on 12 October 2025
• Main coordinator for the MRCP PACES Exams held in Sengkang General Hospital on 27 June 2026
• The American Academy of Aesthetic Medicine, Member | Since 2025
• Dermatological Society of Singapore | Since 2021
• Singapore Medical Council | Since 2013

Co-Investigator in “Pharmacogenetics of Adverse Drug Reactions – Serious Skin Rash (PGx SSR)” Study | 2nd May 2025

1. Chua JY, Long V, PM Yeo, Ding JY, Dua J, NS Chandran, Lim Qasrina, See Tow HX, Sim Wilson, Chong WI, Suendermann O, De Araujo DP, Valderas JM, Phan P, Hsu KJ, Choi CEE. Digital Psychotherapeutic Interventions to Reduce Dermatological Symptom Burden: The Development and Testing of MindMySkin. JAAD International 2025.
2. Ang XL, Yeo PM, Tan YE, Pang SM, Ang CC. Trichophyton indotineae: timely recognition of an emerging pathogen causing persistent dermatophytosis. Singapore Med J. 2025 Jul 24. Epub ahead of print.
3. YL Ting, JZM Lim, PM Yeo, WY Sim. Methaemoglobinaemia: a potential confounder in COVID-19 respiratory failure. Singapore Med J. 2024;65:S24-S25.
4. YW Yew, PM Yeo. Comparison between dupilumab and oral Janus kinase inhibitors in the treatment of prurigo nodularis with or without atopic dermatitis in a tertiary care center in Singapore. JAAD Int. 2023;13:13-14.
5. PM Yeo, NS Chandran. Immune checkpoint inhibitor‐mediated psoriasis treated with biologics. JEADV Clinical Practice. 2023;2:338-40.
6. PM Yeo, ZV Lim, WDV Tan, X Zhao, HY Chia, SH Tan, CCM Teo, WPM Tan. Melanoma in Singapore: a 20-year Retrospective Review of Epidemiology, Disease and Treatment Outcomes. Ann Acad Med Singap. 2021;50:456-466.
7. PM Yeo, SX Lee, Tan YE, Sng LH, CC Ang. Epidemiology, risk factors, and outcomes of adult cutaneous non-tuberculous mycobacterial infection over a 10-year period in Singapore. Int J Dermatol. 2019;58:679-687.
8. PM Yeo, YW Yew, HL Tey. Excluding Severe Bacterial Infection in Neutrophilic Dermatoses with Systemic Features: Negative Predictive Value of Procalcitonin. Ann Acad Med Singap. 2018:47:123-126.
9. SY Ong, LP Ho, PM Yeo, HJ Ng, AL Ang. Marked hypereosinophilia and rash as initial presentation of acute myeloid leukemia with t(8;21). Int J Hematol. 2017;106:149-150.
10. PM Yeo, CC Ang. Jaw Pain in a Pemphigus Patient on Prednisolone, Mycophenolate Mofetil and Denosumab. Ann Acad Med Singap. 2017;46:329-330.

More publications can be found here.